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INTRODUCTION 
The discovery of antibiotics in the beginning of 20th century created hope in 
both the medical community and broader public that bacterial infectious 
diseases will be soon eradicated. It was quickly realized that bacteria develop 
resistance against the new “miracle drugs”. Initially, this was not much of a 
problem because many new drugs were discovered and rapidly entered the 
market. Today, the development of new antimicrobial drugs has decreased due 
to both the high cost of development and low profit margin of antibiotic drugs. 
Simultaneously, antibiotic resistance is emerging and spreading more rapidly 
around the globe. 
While humans discovered antibiotics and began using them as drugs in the 
20th century, microorganisms in the environment have produced these 
compounds for many millions of years. The main role that antibiotics play in 
the environment is the same as in medicine, to fend off unwanted 
microorganisms. Resistance genes are as ancient as antibiotics and have not just 
appeared with the human use of antibiotics, however, the development of 
resistance genes and their spread has been accelerated by the stronger selection 
created by man. 
Currently, antibiotic resistance is a worldwide problem that causes both 
treatment failures and increases the costs in our medical systems. The problems 
caused by antibiotic resistance mostly impact our medical practice; however, 
medicinal use of antibiotics is not the only cause of resistance. Resistance is 
influenced by antibiotic usage in veterinary medicine, agriculture, and fisheries. 
All of this impacts the resistome, which is a term describing all of the known 
and unknown resistance determinants, including determinants in natural 
environment. The impact on the natural environment caused by the emergence 
and spread of resistance is not well understood. Medically relevant antibiotic 
resistance genes are found in the environmental resistome, however, it is not 
clear how our medical use of antibiotics impacts on the resistome, or 
conversely, how the resistome within the natural environment impacts the 
development of medically relevant resistance. 
Understanding how resistance genes transfer would inform us about how to 
fight antibiotic resistance in our hospitals. This work aims to characterize the 
antibiotic resistant bacterial population in aquatic environments to determine 
which phylogenetic bacteria contain resistant strains, which types of antibiotic 
resistance are prevalent, if any, and if there is a link between antibiotic 
resistance and the prevalence of pathogens. In addition, this study attempts to 
assess the impact of human activities on the aquatic environment through 
wastewater management. 
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REVIEW OF LITERATURE 
Antibiotic origins and resistance 
Definition and origins of antibiotic compounds 
Infectious diseases have caused many epidemics throughout the history of 
mankind. Several plagues have wiped out large proportions of the historic 
population. The Black Death plague (1345–1351), caused by a pathogen 
Yersinia pestis, killed more than a third of the European population (24 million) 
and 40 million people worldwide. Not all regions were hit with similar death 
tolls. Southern European countries were savaged more than Northern and 
Eastern countries (Nelson & Williams 2007; McNeill 1976). Infections have 
also been one of the reasons why life expectancy was considerably lower in the 
past than it is today. Surgeries were attempted less frequently, especially more 
complicated procedures, because almost all wounds became infected and 
roughly half of all patients died (Alexander 1985). The death toll caused by 
infections remains significant today, despite advancements in medicine and 
drug development. It has been estimated that more than 20% of deaths annually 
are caused by infectious diseases (Morens et al. 2004; WHO 2008). 
Antimicrobial techniques and substances that are used to treat infections 
have been used for centuries. For example, bone samples from a Sudanese 
Nubia population from between 350 and 550 CE revealed traces of tetracycline 
(Nelson et al. 2010). Antibiotics were not the only treatment available against 
infection. Before the discovery and purification of modern antibiotics, antibiosis 
and antiseptics were used to treat and prevent infections. Antibiosis is the 
treatment of infection with another organism that has an antagonistic effect on 
the infection while curing the patient. Pyocyanase, developed in the 1890s 
(Hays et al. 1945) may have been the first antibiotic (AB) treatment that was 
“discovered” through a study of antibiosis. However, pyocyanase was not 
identified as a purified molecule but rather a cell lysate from a Pseudomonas 
aeruginosa cell culture; it was discovered through the observation that Bacillus 
anthracis could not develop in the presence of P. aeruginosa. Antiseptics were 
used externally to treat wounds and to maintain asepsis. The first recommended 
antiseptic treatment was sodium hypochlorite in the middle of the 19th century 
(Bryskier 2005). 
The first antibiotic substance, Salvarsan, was taken in to use by Paul Ehrlich 
to fight against syphilis at the beginning of the 20th century. By observing dyes 
that specifically colored bacterial, human, or animal cells Ehrlich inferred that 
chemicals could specifically kill these cells. He tested many different 
compounds before finding Salvarsan. His methods formed the basis for future 
systematic and large scale screens to find antimicrobial compounds that target 
specific infectious bacteria (Aminov 2010). Penicillin on the other hand was 
discovered by accident by Alexander Fleming; his Staphylococcus aureus 
containing petri dishes became contaminated with Penicillium notatum while on 
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holiday. In 1929 he published his findings on an active antimicrobial 
substance – penicillin. The publication did not attract attention and was 
forgotten for a number of years; the first penicillin treatment occurred no sooner 
than 1941 (Table 1) (Bryskier 2005). Various problems with the extraction and 
purification of penicillin were largely to blame for the long delay from 
discovery to use. Penicillin is probably the most well-known antimicrobial 
substance, however, the first very successful antibacterial agent was the 
synthetic substance sulfonamide. Sulfonamide was developed by Gerhard 
Domagk using systematic screening methods and is effective against a broad 
spectrum of bacteria: it affects Gram-negative and Gram-positive bacteria. 
Sulfonamides have been in use since 1936 and continue to be used today 
(Aminov 2010; Bryskier 2005). The discovery of streptomycin in 1944 from 
Streptomyces griseus, a species in the phylum Actinobacteria, started a 
systematic screening for antibiotics from the genus Streptomyces. The search 
for new antimicrobials from the group actinomycete continues to this day. The 
period from the 1950s to the 1970s was a golden era for antibiotic discovery 
(Aminov 2010) with a peak of finding new substances in ca. 1970 (Watve et al. 
2001). Since this time only a few new classes of antibiotics have been 
discovered, including the purely synthetic linezolid and a fermentation product 
of Sterpotmyces roseoporus, daptomycin (Raja et al. 2003; Beiras-Fernandez et 
al. 2010; Brickner 1996). The importance of actinomycete in the discovery of 
antibiotics is illustrated by the large proportion of antibiotics produced by this 
group of bacteria. Eighty per cent of antibiotics discovered between 1955 and 
1962 originated from actinomycete bacteria, the majority from Streptomyces 
(Watve et al. 2001). They have contributed to the majority of various classes of 
antibiotics, including β-lactams, glycopeptides, aminoglycosides, macrolides, 
and tetracyclines (Kohanski et al. 2010). 
Selman Waksman defined antibiotics as small molecules produced by 
microbes that inhibit the growth of, or kill, other microbes, with the added 
property of not being toxic to the host (Waksman 1947). Later it was elaborated 
that antibacterial activity should occur at low concentrations and semisynthetic 
molecules should also be included in the definition. Synthetic antibacterial 
agents were historically defined as synthetic antibacterial agents and not 
antibiotics, although today there is no discrimination between the two (Bryskier 
2005). Antibiotics can either be bacteriostatic or bactericidal, with the former 
acting to stall bacterial growth. When a bacteriostatic drug is removed, the cells 
are free to grow again, however, when a bactericidal drug is removed the cells 
will not continue growing. 
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Table 1 Development of antibiotic resistance following its introduction. From 
(Palumbi 2001) 
Antibiotic Year deployed Resistance observed 
Sulfonamides 1930s 1940s 
Penicillin 1943 1946 
Streptomycin 1943 1959 
Chloramphenicol 1947 1959 
Tetracycline 1948 1953 
Erythromycin 1952 1988 
Vancomycin 1956 1988 
Methicillin 1960 1961 
Ampicillin 1961 1973 
Cephalosporins 1960s late 1960s 
 
Antibiotic resistance 
Antibiotic resistance is a phenomenon where bacteria are able to grow in the 
presence of the drug. Currently, antibiotic resistance is a serious problem in 
hospitals and within susceptible communities such as those suffering from 
immunodeficiency. The hope that antibiotics are the “magic bullet”, that will 
eradicate infectious diseases, is long gone. The phrase “magic bullet” was 
originally coined by Paul Ehrlich to describe the desired property of a drug to 
selectively target only disease-causing organisms (Aminov 2010). Resistance to 
new antibiotics has rapidly emerged after introduction of the drug with only the 
time of emergence varying. For example, penicillin resistance was discovered 
months after its introduction (Walsh 2003), methicillin resistance took a 
relatively short time of three years to emerge (Davies et al. 2009), while 
vancomycin resistance was observed more than 30 years after its introduction 
(Table 1). The long delay for vancomycin resistance is explained in part by the 
restricted use of the drug (Walsh 2003; Chambers & Deleo 2009). 
To determine if a bacterial population is able to grow at or near 
concentrations relevant in medicine, the minimum inhibitory concentration 
(MIC) of the bacteria is usually measured by observing the growth of bacteria in 
the presence of an antibiotic at several concentrations. The MIC is defined as 
the smallest concentration where the bacteria are not able to grow; 
concentrations above the MIC will either inhibit the growth or kill the bacteria, 
depending on whether the antibiotic is bacteriostatic or bactericidal. The 
breakpoint concentration above which bacteria are considered resistant is 
determined by clinical breakpoint tests defined by the Clinical and Laboratory 
Standards Institute (CLSI) and The European Committee on Antimicrobial 
Susceptibility Testing (EUCAST). In addition, epidemiological breakpoints are 
also defined (EUCAST). The breakpoint for a bacterial species is defined based 
4
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on MIC tests on the population. Clinical breakpoints are species, disease, and 
strain specific and may change over time. They may even be defined differently 
by different agencies. Clinical breakpoints define the likelihood of a positive 
outcome of antibiotic treatment. Epidemiological breakpoints are species and 
population specific and will not change over time. The epidemiological 
breakpoint is defined as the highest MIC value of the wild-type population that 
has not acquired resistance genes (EUCAST; Kahlmeter et al. 2003). 
MIC is measured by observing bacterial growth at specific AB con-
centrations. The first concentration where there is no growth is the MIC. 
However, this method cannot be used to find tolerant bacteria. Tolerance is a 
phenomenon where bacteria act as if they were being treated by a bacteriostatic 
antibiotic when they are being exposed to a lower concentration of a 
bactericidal antibiotic. They do not grow in the presence of the antibiotic, but 
resume growth when the antibiotic is removed. This impairs effective treatment 
because a sub-population of the initial population persists. This type of sub-
population can be found by measuring the minimum bactericidal concentration 
using similar technique as in the determination of MIC with the added step of 
plating out the surviving population on growth media that does not contain 
antibiotics (Levin & Rozen 2006). 
Once resistance has emerged in an environment it can persist even in the 
absence of selection pressures. For example, resistance to sulfonamide 
antibiotics did not decrease during a period of longer than eight years, even 
though the use of these antibiotics was greatly reduced or even banned within 
UK healthcare systems (Enne et al. 2001; Bean et al. 2005). A different effect 
was observed in Finland where the use of erythromycin and other macrolides 
was restricted due to high levels of resistance to these antibiotics. A significant 
decrease in resistance levels was observed only a few years after the restriction 
(Seppälä et al. 1997; Andersson & Hughes 2011). A similar trend was observed 
after the ban of avoparcin, an analog of vancomycin which also gave rise to 
cross-resistance, after its use as an animal food additive in Taiwan. A 
statistically significant decrease in the number of vancomycin resistant 
enterococci was observed in the farms tested although, resistant isolates were 
still found (Lauderdale et al. 2007). 
There are three main types of resistance mechanisms: antibiotic detoxi-
fication, alteration of the drug binding site, and reducing the accumulation of 
the drug. Antibiotic detoxification involves modifying or degrading the drug. 
For example, β-lactamases cleave the lactam ring of β-lactam antibiotics which 
hinders their binding to transpeptidases which is required for their action 
(Vicente et al. 2006; Kümmerer 2009b). Alteration of the drug binding site is a 
widespread mechanism of resistance. Occasionally, the addition of a single 
methyl group to the right place will render a bacterium resistant, as is the case 
with erythromycin from the family of macrolides; methylating a single adenine 
in the 23S rRNA in the 50S ribosomal subunit makes the organism resistant to 
erythromycin (Gupta et al. 2013). There can also be active transport of the drug 
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out of the cell using efflux pumps not specific to antibiotics whose primary role 
is to export metabolites and toxic substances (Walsh 2003). For example 
Pseudomonas aeruginosa intrinsically possesses efflux pumps that are able to 
transport β-lactams, macrolides, and tetracyclines (Poole 2001). The change in 
the composition of the outer membrane can reduce the permeability of the cell 
envelope to antibiotics. The outer membrane of Gram-negative bacteria is 
significant barrier for hydrophobic antibiotics such as aminoglycosides and 
macrolides, which cross the membrane by diffusion. Lipopolysaccharides in the 
membrane will inhibit diffusion by giving it hydrophilic properties and 
antibiotics will not acquire a sufficient concentration near the target sites in the 
cell (Delcour 2009). 
 
Intrinsic antibiotic resistance 
Resistance can be classified as intrinsic or acquired. This distinction is 
important when determining the mechanism of resistance. Intrinsic resistance is 
a type of resistance that a bacterium has acquired because of its physiology; a 
trait that is encoded by chromosomal genes, is independent of antibiotic 
selection, and not influenced by horizontal gene transfer (Cox & Wright 2013). 
For example, organisms that produce antibiotics are intrinsically resistant to 
these antibiotics. Resistance is required to protect themselves from the self-
produced antibiotic. Some researchers have argued that some form of intrinsic 
resistance is a characteristic of almost all bacterial species (Leclercq et al. 
2013).  
A common example of intrinsic antibiotic resistance is a multi-drug resistant 
phenotype exhibited by Gram-negative bacteria against many classes of 
antibiotics effective against Gram-positive bacteria. This phenomenon is caused 
by the outer membrane of Gram-negative bacteria, which is impermeable to 
many molecules, and efflux pumps, that are capable of effectively reducing the 
concentration of many antibiotics in the cell (Cox & Wright 2013). For 
example, erythromycin has no effect against Escherichia coli and tigecycline 
against Pseudomonas aeruginosa because of their efflux pumps (Piddock 
2006). Acquired resistance would occur if the same efflux pump coding gene 
that gives resistance to P. aeruginosa against tigecycline would be horizontally 
transferred into a susceptible species (Normark & Normark 2002). Lack of an 
AB target would also allow for intrinsic resistance to a specific AB. Isoniazid, 
an important AB treating Mycobacterium tuberculosis infections, inhibits the 
synthesis of mycolic acid, which is required to produce the mycobacterial cell 
wall. Other bacteria do not have mycolic acid in their cell wall and are thus 
intrinsically resistant against isoniazid (Verschoor et al. 2012; Lee et al. 2012). 
Decreased permeability of the outer-membrane and active efflux by efflux 
pumps are thought to be the main causes of intrinsic resistance, however, recent 
studies suggest that deleting some unrelated genes could also make the bacteria 
more susceptible (Cox & Wright 2013). A screen of transposon library of 
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Acinetobacter baylyi revealed genes that were not previously thought to be 
involved in providing intrinsic resistance, however, their disruption made the 
mutants hypersusceptible to the AB. The genes involved were gshA, involved in 
glutathione biosynthesis, and recD, involved in recombination and repair. This 
phenomenon seems to be species specific because E. coli knock-outs of 
homologous genes did not show significant changes in antibiotic MICs (Gomez 
& Neyfakh 2006). This shows that the phenomenon of intrinsic resistance is 
complex and involves more genes than previously thought. Intrinsic resistance 
cannot be classified based on a single gene. The same gene can provide intrinsic 
resistance in one species but acquired resistance in another.  
 
Acquired antibiotic resistance 
Acquired antibiotic resistance is a type of resistance that is acquired by 
mutation of bacterial chromosomal genes or by horizontal gene transfer of 
resistance genes (Palmer & Kishony 2013). All three different resistance 
mechanisms play an important part in acquired resistance; the actual mechanism 
depends on the antibiotic. For β-lactams the most common mechanism is drug 
modification by β-lactamases (Smet et al. 2010). Tetracycline resistance is 
mainly provided by drug efflux or by a ribosomal protection protein that helps 
to release tetracycline from the ribosome (Thaker et al. 2010; Roberts & 
Schwarz 2009). The most frequent resistance mechanisms that work against 
chloramphenicol, another protein synthesis inhibiting antibiotic, are drug 
modification and efflux (Murray & Shaw 1997; Roberts & Schwarz 2009). To 
differentiate acquired resistance from intrinsic resistance we need to determine 
if the resistance is species specific or population specific. The latter indicates 
that resistance has been acquired via natural selection in relatively recent times 
(McDermott et al. 2003). Usually, the term resistance in medicine and animal 
husbandry implies acquired resistance (Levy & Marshall 2004). 
The rapid and wide dissemination of newly arisen resistance genes is, in 
part, due to mobile genetic elements (MGE) and horizontal gene transfer 
mechanisms (which are discussed later) (Stokes & Gillings 2011). There are 
many types of MGEs that resistance genes can move with between organisms. 
These include transposons, integrons, integrative conjugative elements, 
plasmids, and genomic islands (see Figure 1 for hierarchical complexity of 
mobile elements), however, only plasmids are able to autonomously replicate. 
Other elements require integration into the host’s chromosome or into a plasmid 
through either site specific or homologous recombination or via transposition. 
The resistance genes are not fixed to the MGEs and are able to move from one 
organism to other, thus creating MGEs that confer resistance to several 
antibiotics (Stokes & Gillings 2011). For example, genes for AmpC enzymes 
are found in plasmids ranging in size from 7 to 180 kb. Besides ampC, these 
plasmids often carry resistance genes for tetracycline, sulfonamide, 
aminoglycosides, chloramphenicol, and trimethoprim (Philippon et al. 2002). 
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Figure 1. Hierarchical complexity of mobile resistance elements participating in the 
mobilization, spread, and maintenance of antibiotic resistance genes, with modifications 
from (Cantón et al. 2012). 
 
Many resistance genes are not always associated with MGEs; they can also be 
found in the bacterial chromosomal DNA without any association with MGEs. 
In β-lactamases within the class D OXA family, similarity based on the amino 
acid sequence of the protein varies from 19 to 96%. The majority of class D 
plasmid borne genes are from Eneterobacteraceae, Pseudomonas spp. and 
Acinetobacter spp. while chromosomal genes are obtained from Aeromonas, 
Legionella, Shewanella, and Campylobacter species (Poirel et al. 2010a). It is 
not easy to find the origin of a medical resistance gene, however, in a few cases 
a culprit has been proposed. The origin of qnrA, a gene giving resistance to 
quinolones by protecting DNA gyrase and topoisomerase IV, is linked with an 
environmental species Shewanella algae (Poirel et al. 2005). For some class A 
CTX-M type plasmid encoded β-lactamases, the progenitor originates from 
Kluyvera ascorbata, an opportunistic pathogen with low clinical significance. 
The chromosomally encoded gene of K. ascorbata had a high sequence 
similarity with CTX-M sequences, including parts of the flanking sequences of 
the genes (Humeniuk et al. 2002). CTX-M type genes belong to the extended-
spectrum β-lacatamses (ESBLs), which are able to hydrolyze expanded 
spectrum cephalosporins and monobactams. Because of their wide and fast 
dissemination, beginning in the year 2000, the phrase “CTX-M pandemic” has 
been used. The rapid spread is facilitated by MGEs and successful bacterial 
clones (Cantón et al. 2012). 
5
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Antibiotic resistance in the natural environment 
Antibiotic resistance is a concern because it increases mortality and morbidity 
in both healthcare (Vicente et al. 2006) and veterinary settings, and induces a 
significant economic cost (Levy & Marshall 2004; Smith & Coast 2013). 
Resistance in medicine and animal husbandry has been the primary concern and 
few consider that the spread of AR in the environment is either a problem or 
threat to either human health or the environment.  
Most instances of antibiotic resistance in the environment have been 
discovered in soil bacteria. Resistance genes have functioned in the 
environment well before humans began using antibiotics in medicine or perhaps 
before mammals evolved from therapsids for that matter. Using phylogenetic 
analysis of β-lactamase protein sequences, we now understand that these 
resistance genes are millions of years old. These genes also existed on mobile 
genetic elements before the human use of antibiotics (Hall & Barlow 2004; 
Barlow & Hall 2002). We ought to study resistant organisms in the natural 
environment because all of the various environments that house antibiotic genes 
are connected (Figure 2). Resistance that has been selected for in one 
environment can ‘hitchhike’, one way or another, to other environments. The 
movement of antibiotic resistance between environments is discussed in more 
detail below. 
 
 
Figure 2. A structured compartmental view of how antibiotics and antibiotic resistance 
genes are linked between the human and natural environment. Modified from (Davies & 
Davies 2010; Hawkey & Jones 2009) 
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Antibiotic resistance in soil 
As mentioned above, most of the antibiotics in use today originate directly from 
soil dwelling bacteria or are derivatives of these compounds. It is estimated that 
more than 80% of the antibiotics in clinical use originate from soil bacteria 
(Torres-Cortés et al., 2011). 
Knapp et al. (2010) found that the quantity of ARGs in soils has increased 
during the time humans have used antibiotics. The study made use of archived 
soil samples from 1940 to 2008 to look for the number of antibiotic resistance 
genes quantitatively using qPCR. The authors saw an increase in the number of 
resistance genes, however, the increase was not universal, and differed between 
both resistance genes and soil types. The increase of β-lactamases and 
tetracyclines was more significant over the same time period compared with 
erythromycin resistance genes (Knapp et al. 2010). Although their study shows 
that antibiotic resistance in soil environment has increased during the use of 
antibiotics by humans, it also shows that antibiotic resistance genes could have 
been selected by the pre-human-occurrence of antibiotics in soils. 
The presence of antibiotic resistance genes in the environment before 
humans began using the drugs is clearly shown by D’Costa et al. (2011) who 
used non-culture methods to PCR amplify putative resistance genes from 
permafrost cores that were about 30,000 years old. They were able to amplify 
tetracycline, β-lactam, and vancomycin resistance genes, thereby demonstrating 
a link between 30,000 year old and contemporary resistance genes (D’Costa et 
al. 2011). Barlow and Hall estimate that the age of β-lactamase genes can be in 
millions, instead of thousands of years (Hall & Barlow 2004). Antibiotic 
resistance is not only found in ancient and old samples, but also from locations 
untouched by anthropogenic activity. This shows that resistance genes and 
resistant organisms can be found in pristine soil environments (Allen et al. 
2009; Bhullar et al. 2012).  
In light of this evidence it seems logical that resistance against antibiotics or 
against modified isoforms of natural antibiotics may be easy to find in the 
environment. However, the environment also contains resistance genes for 
synthetic antibiotics. During their search for resistance genes in the genus 
Streptomyces, D’costa et al. (2006) found that all isolates tested were resistant 
to more than one antibiotic, including synthetic antibiotics, some long in use 
and others new to the market (D’Costa et al. 2006). There is also no difference 
in the rate that resistance emerges against natural antibiotics and synthetic 
antibiotics (Table 1 and (Bryskier 2005)).  
Antibiotic resistance is ancient and has been mostly found in soil bacteria. 
While superficially similar resistance is found in healthcare settings, direct 
proof that resistance genes in pathogens and environmental bacteria share a 
common origin has only recently been produced. Forsberg et al. (2012) found a 
direct link between soil bacteria and clinical pathogens using a metagenomic 
approach to find resistance genes from cultivated environmental bacteria, 
mainly Proteobacteria. They found 18 genes that had 100% and 32 that had 
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>90% amino acid identity to entries from pathogens in GenBank. This level of 
similarity implies horizontal gene transfer (HGT) because the organisms studied 
were only distantly related on an evolutionary scale. In addition, the majority of 
the resistance genes discovered were formerly unknown (Forsberg et al. 2012). 
The study by Forsberg et al. (2012) is one of only a few that has linked 
environmental and clinical resistance genes, however, it is not the first to make 
use of metagenomics to enrich our knowledge regarding the diversity of 
resistance genes in the soil environment (Allen et al. 2009; Lang et al. 2010; 
Donato et al. 2010). Metagenomics has proven to be an effective tool for both, 
to discover new resistance genes and exploring the diversity of the resistome in 
the environment. Currently, culture based methods are not as effective in this 
search (Monier et al. 2011; Lefevre et al. 2008) because only 1 – 5% of bacteria 
are culturable (Amann et al. 1995). 
 
Antibiotic resistance in the aquatic environment 
Aquatic environments are important reservoirs for antibiotic resistance because 
resistant organisms and MGEs from a variety of sources, together with 
increased concentrations of antibiotics from our waste stream, all come together 
in this environment. AR bacteria enter the aquatic environment via both treated 
and untreated sewage and agricultural run-off (Baquero et al. 2008). Production 
of antibiotics in current use have not been found in aquatic bacteria, however, 
traces of clinical antibiotics end up in the aquatic system from our waste stream. 
In some conditions between 70 to 80% of the antibiotic can pass through the 
organism (animal or human) unchanged when the antibiotic is orally 
administered (Sarmah et al. 2006; Kümmerer & Henninger 2003) and end up in 
the sewage system which is also not able to completely remove these 
compounds (Kümmerer 2009a; Kümmerer & Henninger 2003). The con-
centration of antibiotic compounds in surface water can range from a few ng per 
L to more than a µg and typically hundreds of ng per L can be found in ground 
water. Concentrations differ between antibiotics and specific environments 
(Kümmerer 2009a). 
Antibiotic resistance and antibiotic resistance genes have been studied 
extensively in aquatic environments. Culture based methods are most 
commonly employed and many studies concentrate on medically relevant 
organisms such as methicillin-resistant Staphylococcus aureus (MRSA), 
Pseudomonas aeruginosa and other Pseudomonas spp., Aeromonas spp., and 
Enterococcus spp. (Morris et al. 2012; Roberts et al. 2013; de Vicente et al. 
1990). More recently, PCR based methods have been used to determine the 
resistance genes involved (Dhanji et al. 2011; Girlich et al. 2011). This can only 
be performed on genes that are known and most studies target medically 
relevant genes such as vanA that provides resistance to vancomycin, a drug 
considered as a “last resort” drug (Cytryn 2013), mecA that encodes for a 
penicillin binding protein that has reduced affinity for β-lactams (Hartman & 
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Tomasz 1981), and other less infamous genes. With the use of culture based 
methods it was established that antibiotic resistance in the aquatic environment 
is prevalent (Boon & Cattanach 1999; Blasco et al. 2008). Resistant organisms 
were found among opportunistic pathogens (Girlich et al. 2011; Blasco et al. 
2008) and organisms that did not relate to pathogens (Henriques et al. 2006), 
which shows that resistance in the water is as widespread as it is in the soil and 
does not confine itself to a few bacterial genera. The use of moleuclar methods 
has broadened the picture, including information about organisms that do not 
grow on conventional media or laboratory conditions. Suzuki et al. (2013) 
found, by measuring the quantity of sul1, sul2, and sul3 genes in both fresh 
water and marine water that both the presence and quantity of antibiotic genes 
differs between the cultivable population and the entire population. Using 
culture based methods, sul3 was not found in marine samples, however, was 
present when the gene was amplified from community DNA. 
Once antibiotic resistance has emerged it is seen to persist and can persist in 
a formerly polluted site in the absence of selection. Tamminen et al. (2011) used 
quantitative PCR (qPCR) to observe that the copy numbers of tetracycline 
resistance genes remained elevated in a fish farm even though antibiotics had 
not been administered for several years. Antibiotic resistance genes are also 
found in pristine aquatic and related environments (Dib et al. 2009; Segawa et 
al. 2013) as was the case with pristine soil environments. For example resistant 
organisms were found in alpine lakes. Moreover, most of the isolated and 
cultured organisms were resistant to several antibiotics (Dib et al. 2009). 
 
 
Antibiotic resistance Hot-Spots 
Having established the ubiquity of antibacterial resistance in both human and 
natural environments we shift the discussion to the nature of how resistance is 
transferred in environments where the potential of resistance transfer is the 
highest. A number of potential hot-spots for both the presence and spread of 
antibiotic resistance are healthcare settings, veterinary facilities, and waste-
water treatment plants (WWTP) and their surrounding areas. These 
environments are highlighted because of the simultaneous presence of antibiotic 
selection, the presence of both pathogenic and non-pathogenic bacteria, and the 
possibility of transferring resistance between organisms, people and the natural 
environment. 
 
Healthcare settings as a potential hot-spot 
Healthcare settings are the most obvious hot-spots for antibiotic resistance to 
develop. The consumption of antibiotics is high, thus inducing strong selection, 
patients turnover rapidly, and many pathogens grow in close proximity within 
an often confined and relatively small space.  
6
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It is important to consider antibiotic resistance in healthcare settings because 
many patients are admitted with one illness and subsequently acquire 
nosocomial infections. Because of the presence of strong selection in this 
environment, these infections can be resistant to several antibiotics administered 
at high concentrations. Resistance can develop through both mutations and 
HGT, as previously mentioned, and pathogenic bacteria with higher mutation 
rates have been observed, although no correlation between higher mutation rates 
and antibiotic resistance was found (Denamur et al. 2002; Henderson-Begg et 
al. 2010). Antibiotic treatment itself will select for a resistant population, even 
when the treatment uses a combination of antibiotics. This was shown in vitro 
by Pena-Miller et al. (2013) where a resistant subpopulation was present after 
treatment. Mwangi et al. (2007) observed that resistance can appear during 
treatment in a stepwise manner. HGT via MGEs has been shown to be a 
common mechanism whereby bacteria acquire resistance (Nakamura et al. 
2004). Many of the resistance genes are carried by integrons that are not able to 
actively move between organisms, however, they can insert themselves into 
mobile plasmids and transposons. Integrons are bacterial genetic elements that 
can contain and express many resistance genes (Stalder et al. 2012; Cantón et al. 
2003). Of primary concern are the resistance and virulence integron cassettes 
that hold genes for several antibiotics. Such cassettes can travel together to 
susceptible organisms making them multiresistant with a single transfer event 
(Partridge et al. 2009). Selection preserves all genes on an MGE even if only 
one resistance gene is under selection. This preserves multiple resistance genes 
simultaneously thereby nullifying the strategy of rotating antibiotics within 
clinics and hospitals. Although many clinically relevant pathogenic species can 
also be found in the environment, few studies have found direct contacts 
whereby resistance is transferred between pathogenic and environmental 
bacteria, as mentioned above. A few studies report a link between resistance 
genes from clinical pathogens and other environments by comparing the 
sequences of the resistance genes (Poirel et al. 2005; Bonnet 2004; Forsberg et 
al. 2012). 
Both resistant bacteria and the genetic material that confers resistance can be 
disseminated to other environments through both patient transfer and waste 
water as was observed with Enterococcus sp. which moved into the natural 
environment (Novais et al. 2005; Varela et al. 2013). There are also reports that 
show the presence of organisms that have acquired resistance to the same 
antibiotics as clinical bacteria in the absence of a direct clonal connection 
between the environments (Morris et al. 2012; Leclercq et al. 2013). 
 
Agriculture as a potential hot-spot 
The use of antibiotics in agriculture accounts for approximately 80% of all 
antibacterial use in the USA and 30% in the EU (Kemper 2008). In the EU, the 
use of antibiotics as growth enhancers was banned in 2005 (Zheng et al. 2011), 
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however, it is still common practice in the US and other countries (Sarmah et al. 
2006). Because of the widespread use of antibiotics in agriculture and both 
direct and indirect contact between agricultural products, humans, and other 
environments, agriculture is considered to be an important contributor to the 
global antibiotic resistome. Agriculture contributes to the resistome through 
both the dissemination of resistant bacteria directly to humans and by leakage of 
agricultural waste containing resistance determinants, organisms, and antibiotics 
into the surrounding environment. 
The transfer of bacteria from animals to farmers was nicely shown by 
Oppliger et al. (2012) where they collected nasal samples to look for the 
presence of S. aureus from pigs, their farmers, and a few veterinarians. The 
dominant genotypes found in the pigs were also present in the humans tested, 
although the genotypic variability was higher in humans. The occurrence of 
antibiotic resistance, including multiple AB resistant bacteria, was similar 
between pigs and farmers and differed from healthy subjects without contact to 
agriculture (Oppliger et al. 2012; Armand-lefevre et al. 2005). In South-Korean 
chicken farms, antibiotic resistant Salmonella spp. was found in samples taken 
from egg shells and boots which are both likely to have contact with humans . 
Multi-resistance was common among the isolates and only 14% were 
susceptible to the antibiotics tested (Rayamajhi et al. 2010).  
Between 25 to 75% of the administered AB dosage passes through the 
organism, is excreted with the feces in an unaltered or partially altered form, 
and can persist in the soil after the manure is used as a fertilizer (Chee-Sanford 
et al. 2001). In addition to applying antibiotics with the manure onto the fields, 
the manure itself contains resistant bacteria and resistance determinants 
(Jechalke et al. 2013). The effect on the local resistome after applying manure 
does not last for very long; the number of resistance genes and resistant 
organisms in the soil decreases over time (Jechalke et al. 2013; Heuer & Smalla 
2007; Sengeløv et al. 2003). However, this does provide an opportunity for AR 
to spread with the use of manure. Chee-Sanford et al. (2001) looked for 
tetracycline resistance genes in both lagoons and underlying groundwater near 
two swine production facilities. They found tetracycline resistance genes from 
sampling points downstream of the facilities while only one gene was found in a 
control well upstream. This shows that leakage from production facilities has an 
impact on the groundwater downstream (Chee-Sanford et al. 2001). 
 
WWTP as a hot-spot 
WWTP are considered hot-spots because they receive waste and sewage water 
from large urban areas, including hospitals, and house an environment with 
dense bacterial loads (Schlüter et al. 2007). Sewage contains different species of 
both pathogenic and non-pathogenic bacteria that can be classified as either 
resistant or non-resistant. Some of these are released into the environment after 
the treatment process (Varela & Manaia 2013) 
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The presence of resistance genes in both the activated sludge and outflow 
water of WWTPs has been observed many times, however, Szczepanowski et 
al. (2009) stands out as a large scale study. They extracted plasmids from 
resistant bacteria, which were then selected with culturing methods, followed by 
a scan for resistance genes using PCR amplification. The genes they amplified 
provide resistance to medically important groups of antibiotics. They were able 
to detect 140 different resistance genes that, upon sequencing, allowed them to 
identify sequences that were identical or highly similar to known sequences 
from various databases (medical strains). Using metagenomics, Zhang et al. 
(2011) showed that most resistance genes found in activated sludge are 
tetracycline, macrolide, and multidrug resistance genes. The WWTP reduces the 
total number of bacteria and also the numbers of resistant bacteria, however, a 
few studies observe that the relative numbers of some species significantly 
increase in the effluent. In addition, waste water treatment can select for a 
specific resistance, for example resistance to fluoroquinolones (Łuczkiewicz et 
al. 2010). Resistance to other antibiotics have also been observed, but not with 
increased frequency (Ferreira da Silva et al. 2006; Łuczkiewicz et al. 2010). 
Many studies make use of culture based methods and typically use specific 
species such as Escherichia coli, Enterococci spp., and Acinetobacter spp. as 
representative of the larger population (Rizzo et al. 2013). It is important to note 
a major limitation of applying culture dependent methods to describe the 
population: of the majority of species within the bacterial population are not 
cultivatable.  
The final effluent is not always simply released into the environment. In 
more arid environments effluent is often used to irrigate crops. This potentially 
increases the spread of AR by inoculating the fields with resistant organisms 
and genetic agents, however, the group led by E. Cytryn disproved this 
hypothesis. They studied several fields that were irrigated with either treated 
wastewater or fresh water and found that the number of resistant organisms 
found in the soil was similar between fields. The field treated with fresh water 
had a significantly higher number of resistant organisms, however, the total 
number of bacteria, including resistant bacteria, was orders of magnitude higher 
in the treated wastewater. Of the resistance genes tested, no significant 
differences were observed in the copy numbers between soils irrigated with 
treated wastewater or freshwater (Negreanu et al. 2012). 
 
 
Dissemination of antibiotic resistance 
As mentioned above, antibiotic resistance is not a local phenomenon. The rise 
of resistance in one place will influence the rise of resistance in other places. 
Dissemination of resistance can, broadly speaking, occur by both the physical 
spread of resistant organisms and horizontal gene transfer. 
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Horizontal gene transfer and  
the dissemination of antibiotic resistance 
Horizontal gene transfer (HGT) is a process where the recipient organism 
acquires extra genetic material in some process other than cell division. HGT is 
one of the main reasons why antibiotic resistance is both rapidly and widely 
spread. There are three mechanisms whereby HGT occurs: transformation, 
which is the active uptake of extracellular DNA from the environment (Lorenz 
& Wackernagel 1994); conjugation, which involves DNA transfer requiring 
energy and cell contact (Waters & others 2001); and transduction, which is 
bacteriophage mediated transfer of genetic material (Jiang & Paul 1998). 
HGT is important in dissemination because it helps multiresistance to arise 
and resistance to spread faster (Barlow 2009; Roberts 2008). Many of the 
resistance genes that have been found on MGEs are able to transfer between 
organisms and species (Marti & Balcázar 2012; Pérez-Pérez & Hanson 2002; 
Poirel et al. 2005; Schlüter et al. 2007). The relative frequency rates of the three 
HGT mechanisms are currently not known in the natural environment, however, 
if one considers the number of bacteria in the various environments, smaller 
transfer rates could still add up to a considerable number of total HGT events. 
Jiang & Paul (1998) deduced from their measurements that up to 100 
transduction events per liter per day can occur in a marine environment under 
ideal conditions. Using chromosomal DNA and plasmid DNA in mesocosm 
experiments, the frequency rate of transformation was found to be in the range 
of 10–10 – 10–4 transformation events per viable cell. Both the frequency and 
efficiency depend on environmental factors such as pH, humidity, and the type 
of soil (Lorenz & Wackernagel 1994). 
 
Dissemination of antibiotic resistant organisms 
Although bacteria themselves cannot travel long distances using their own 
power, they are small enough to be carried by physical forces as wind and water 
and also by other organisms. All of these physical mechanisms can relocate 
material great distances, and with it bacteria, viruses, and DNA that can affect 
the new environment. 
Both animals and birds can act as vehicles for bacteria. MRSA can transfer 
from farm animals to farmers (Oppliger et al. 2012; Fluit 2012). Wild animals 
that live closer to humans were shown to carry more antibiotic resistant bacteria 
than animals living further away from human influence (Gilliver et al. 1999; 
Österblad et al. 2001). Dib et al. (2009) discuss that resistant bacteria could be 
dispersed by birds because resistant organisms were found in both natural water 
and bird feces. 
The most prominent vehicles for bacterial movement are, of course, humans. 
We consume a large portion of the antibiotics administered and thus create a 
selection environment within our bodies. We also travel large distances and are 
7
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in contact with others. The rapid spread of viral diseases around the globe is a 
prime example of how effective we are as disease carriers (Enserink 2013). This 
also applies to bacterial infections, albeit not as rapidly. The consumption of 
agricultural products that are produced in remote locations across the globe is 
also facilitating the dissemination of antibiotic resistant bacteria and genetic 
material (Buchholz & Bernard 2011). 
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RESULTS AND DISCUSSION 
Aims of the study 
Current levels of antibiotic resistance already constitute a major problem in 
medicine and several studies predict this problem will become worse over time 
with the development of resistance genes and resistant organisms in various 
environments (McKennan 2013; Smith & Coast 2013). Despite the magnitude 
of the problem with antibiotic resistance in medicine, it is not known if the 
natural environment either contributes to the medical resistome or acts as sink 
where resistance genes eventually end up. 
The aim of this dissertation is to characterize antibiotic resistance within an 
aquatic bacterial population to establish a potential link between resistance 
genes found in human pathogens and aquatic bacteria. Specific aims are as 
follows: 
 to study the variability and phylogenetic affiliations within a population of 
freshwater bacteria that displays antibiotic resistance; 
 to determine the occurrence of multidrug resistance in the aquatic 
environment; 
 to assess if there are associations between environmental and clinical 
resistance genes; 
 to study the potential impact of WWTPs in disseminating antibiotic 
resistance genes to the downstream environment. 
 
 
Co-occurrence of resistance to different antibiotics 
among aquatic bacteria (I)  
Studies of antibiotic resistance are biased for medical/veterinary or medically 
related bacteria and perhaps rightfully so. On the other hand, the wider 
discussion about the dissemination of resistance requires a broader 
characterization of antibiotic resistance within environmental populations. 
We chose to characterize the antibiotic resistance of a random population of 
fresh-water river bacteria in Estonia using cultivation-based methods. While 
cultivation methods are biased (Kaeberlein et al. 2002), they provide both an 
opportunity to study the phenotype of the selected isolates and the possibility of 
linking antibiotic resistance and phylogenetic affiliation. The medium used for 
the isolation of environmental bacteria was formed from four volumetric parts 
of filtered natural water and one part distilled water. It was further 
supplemented with 5g/l of peptone and 1g/l of yeast extract. This medium 
allows one to isolate a wide phylogenetic and physiological range of bacteria. 
Five antibiotics were chosen as selective agents: ampicillin (100 µg/ml), 
chloramphenicol (30 µg/ml), kanamycin (20 µg/ml), norfloxacin (2 µg/ml), and 
tetracycline (20 µg/ml). These antibiotics were chosen to cover a range of drug 
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targets: DNA replication, protein synthesis, and cell wall synthesis. The 
concentrations of these antibiotics were selected to be close to the EUCAST 
MIC cutoff values for resistance (EUCAST). 
Sampling was carried out at two locations in duplicate on five different dates 
over four months from July to October 2008, thus providing 10 samples (Figure 
3). Each sample was plated out to five different selective media, each 
containing one of the five antibiotics mentioned above. The isolates (n = 760) 
were selected for analysis by choosing morphologically different colonies, but 
no less than 10 colonies per plate; differences were evaluated visually. The 
phylogeny of the isolates was assessed by sequencing the 16S rRNA gene and 
comparing with data from Ribosome Database Project (Wang et al. 2007). The 
isolates belonged to nine phylogenetic classes and 59 genera (I, Figure 1). 
Almost half (49%) of the 760 isolates belonged to Gammaproteobacteria and 
more than half of these (58%) were Pseudomonas spp. The selection of 
Gammaproteobacteria is a known plating bias of aquatic bacterial communities 
(Eilers et al. 2000) and the phylogenetic composition of the population we 
studied is in accordance with previous studies (Pinhassi et al. 1997; Simu et al. 
2005; Selje et al. 2005). 
 
 
Figure 3. Map of different sampling stations. Red circles indicate the stations for 
freshwater samples; green circle indicates the cities where the WWTP samples were 
taken and in Tartu the location of the WWTP. Blue arrow indicates the effluent runoff 
to the river Suur-Emajõgi in Tartu. Figure is a modification and combination from 
www.OpenStreetMap.org and www.FreeVectorMaps.com. 
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For every isolate we tested the concentration dependence of antibiotic resistance 
using six antibiotics (ampicillin – 10, 25, 100 µg/ml; meropenem – 0.3, 3, 
30 µg/ml; norfloxacin – 0.5, 2, 10 µg/ml; chloramphenicol – 1, 5, 30 µg/ml; 
kanamycin – 1, 5, 20 µg/ml; tetracycline – 1, 5, 20 µg/ml). In addition to the 
antibiotics used in the initial selection, meropenem, of the family carbapenem, 
was included because carbapenem resistance is a characteristic problem in 
Estonian medical settings (Lõivukene et al. 2006). Because of the variability in 
the growth rates of environmental bacteria, we did not employ standard MIC 
analysis. Instead, we tested the antibiotic resistance by growing the bacteria in 
the presence and absence of the antibiotic over a longer timescale while 
measuring the optical density (OD). For each isolate and antibiotic pair, a 
resistance value (ܴ) was calculated using the ratio of the lowest OD value in the 
presence of the antibiotic to the lowest OD value in the control experiment. For 
each antibiotic at each concentration we calculated the sum of all pairwise 
differences (ܵ) between resistance values: 
 
ܵ =෍෍ abs൫ܴ௜ − ௝ܴ൯
଻଺଴
௝ୀଶ
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For each antibiotic we selected the concentration with the largest sum of all 
pairwise differences (ܵ), thus choosing the concentration where the diversity in 
resistance between isolates was the greatest. The concentration with the largest 
ܵ provides the greatest chance of differentiating resistant bacteria from 
susceptible bacteria. 
Resistance was considered at the genus level with genera that contained 
more than 20 isolates (n=8). In some genera, almost all isolates were resistant to 
a particular drug with an average resistance value above 0.8. This could indicate 
intrinsic resistance for the entire genus. We also observed that some genera 
contain isolates that are mostly all sensitive to a given antibiotic (I, Figure 2A). 
One exception is resistance to meropenem. This antibiotic displays an average 
resistance value above 0.5 for all genera analyzed, thus potentially indicating 
that the concentration with the maximum ܵ was not high enough to differentiate 
resistant bacteria from susceptible bacteria. No genus was found to be fully 
susceptible or fully resistant; none of the antibiotics was able to inhibit the 
growth of all isolates in a genus. In every genus analyzed we found at least one 
antibiotic that was able to inhibit the growth of most isolates while some of the 
other antibiotics were not able to inhibit any of the isolates (I, Figure 2B). 
To evaluate the diversity of resistance values within each genus we 
constructed a histogram of the ܴ values (I, Figure 3 and Figure S1). In some 
cases a wide distribution of resistance values was formed of two sub-
populations that did and did not display resistance. Two sub-populations within 
a genus suggest that the resistance observed is acquired. Some genera (e.g. 
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Stenotrophomonas, Chryseobacterium, Flavobacterium) displayed high levels 
of resistance to several antibiotics. We tested if this is either a result of 
“superbugs” or a result of a random distribution of intrinsic and natural 
resistance levels. We tested this by summing up the resistance values of all six 
antibiotics for every isolate within a genus and plotting a histogram of these 
values (I, Figure 4). The distribution of summed resistance values form a 
normal distribution, which suggests that multidrug resistance happens by 
chance and there is no selection for it in the freshwater environment studied. 
Although resistance levels are randomly grouped, it does not exclude the 
possibility that some forms of resistance cannot group together. To test this, we 
calculated correlation coefficients between all antibiotic pairs in the dataset (I, 
Figure 5). In total, we identified eight significant (p < 0.05) positive and four 
negative correlations. The antibiotic pair tetracycline and chloramphenicol 
displayed the highest correlation coefficient (r=0.669, p=0.001). However, the 
resistance correlation using all isolates can be influenced by a small number of 
phylogenetic groups that dominate the correlation. To evaluate this we looked 
for resistance correlations among the eight largest genera with >20 isolates (I, 
Figure 5). A strong positive correlation between resistance to tetracycline and 
chloramphenicol was found in six out of eight genera. In addition, there were 
resistance correlations within a given genus that differ from the overall test 
population. The results of this analysis suggest that resistance for tetracycline 
and chloramphenicol may be facilitated by a common multidrug efflux pump 
or, alternatively, the two separate resistance determinants are found on the same 
MGE that is capable of efficient HGT. 
 
 
Aeromonas and Pseudomonas Species as Carriers 
of ampC FOX Genes in Aquatic Environments (II) 
The use of β-lactams, a class of commonly used antibiotics, has always been 
followed by emergence of antibiotic resistance that is mostly driven by β-
lactamases (Bradford 2001; Jacoby & Munoz-price 2005; van Hoek et al. 2011). 
ampC genes have been found among pathogenic enterobacteria and is an 
important resistance gene in medical pathogens (Philippon et al. 2002). β-
lactams and β-lactamases are evolutionarily ancient and thus originate from the 
environment. This might manifest itself in their wider dissemination in the 
environment. To test this hypothesis, we investigated if the resistance genes 
from the class ampC could be found in environmental freshwater bacteria.  
This study was performed using the previously mentioned population of 
river bacteria with additional bacteria from Lake Võrtsjärv and river Pede. In 
total, 214 plus 760 isolates were analyzed. All bacteria were isolated from 
selective media containing at least one antibiotic as described in Paper I. The 
ampC genes were detected using multiplex PCR (Pérez-Pérez & Hanson 2002) 
that is able to amplify all major families of plasmid-carried ampC genes (e.g., 
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those for CMY, DHA, MOX, FOX, and ACC). We detected ampC genes in 48 
isolates and all of these belonged to the FOX family. Forty five of these isolates 
were isolated from ampicillin containing media and the other three were from 
tetracycline containing media. 
The 16S rRNA gene in these 48 isolates was amplified using universal 
primers (Lane 1991, Paper I) and sequenced to determine the phylogenetic 
affiliation of the FOX positive isolates; the affiliation was assessed using data 
from the Ribosome Database Project (Wang et al. 2007). This showed us that 30 
(65%) out of 48 isolates were Aeromonas spp. and 12 (25%) were Pseudomonas 
spp. (II, Figure 1A). Over the entire study population, 7% are Aeromonas spp. 
and 23% are Pseudomonas spp. It could be supposed that the high percentage of 
Pseudomonas spp. and Aeromonas spp. in the study population is the reason we 
found FOX-positive isolates belonging to these genera. However, this is not 
likely to be true because we did not find FOX-positive isolates from other 
genera with equally high isolate representation such as Stenotrophomonas and 
Chryseobacterium. 
The PCR products from the FOX genes in the 48 isolates were compared 
with FOX variants described in public databases (Genbank and EMBL-EBI). 
By clustering the gene variants using Bayesian inference of phylogeny 
(MrBayes; II, Figure 1B), the FOX genes from our population clustered into 
four distinct groups with an intragroup similarity of 100% and were 
phylogenetically distinct from a separate node formed from the mostly 
enterobacterial FOX genes found in the public databases. We mapped the four 
FOX gene variants onto the 16S rRNA gene phylogenetic tree of the isolates (II, 
Figure 1A) to see how they are distributed among the isolates. This mapping 
demonstrated that one variant (VAR1) dominated over all others; in addition, all 
variants were represented among Aeromonas spp., and only two were found in 
Pseudomnas spp. 
We only analyzed the relation of the population structure and distribution of 
FOX gene variants in Aeromonas isolates because not all of the FOX variants 
were found in Pseudomnas spp. The population structure was studied using 
multilocus sequence typing (MLST), using six houskeeping genes: gyrB, groL, 
gltA, metG, ppsA, and recA (Martino et al. 2011). Every Aeromonas isolate 
(n = 71) was included in the MLST gene amplification. Because MLST was 
unable to function as expected for all of the six housekeeping genes (PCR 
amplification from all isolates was not achieved), we chose isolates where three 
of the MLST genes (gltA, metG, recA) were successfully amplified. With these 
genes 19 FOX-containing isolates and 23 FOX negative isolates were included 
in the analysis. The three MLST gene sequences were concatenated, aligned, 
followed by the construction of a maximum parsimony tree (II, Figure 2). From 
this we saw that most FOX-positive isolates grouped together and were separate 
from FOX-negative isolates. We did not observe an association between the 
FOX gene variants and the location of origin of the isolate (chi-square test, 
P > 0.05), however, we did find that more FOX gene variants were found in 
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autumn samples as opposed to summer samples (P = 0.02). The seasonal 
dependence may be influenced by autumn rains that tend to bring together 
material from adjacent agricultural fields and other streams. After making a 
phylogenetic tree using the 16sRNA gene sequences, we observe two 
populations. This suggests an inflow of a resistant population from elsewhere. 
Because the clustering of FOX-positive and FOX-negative isolates was found to 
be distinct, we conclude that there has been no recent horizontal transfer of 
FOX genes because phylogenetically closer isolates were seen to carry a 
specific FOX gene variant. 
 
 
Relative abundance of antibiotic resistance genes  
in conventional wastewater treatment plants (III) 
WWTPs are considered to be important hot-spots for the selection and spread of 
antibiotic resistance (Jury et al. 2011; Moura et al. 2010). It has been shown that 
high concentrations of both antibiotic compounds and resistance genes coexist 
in WWTPs (Kim & Aga 2007). The spread of antibiotic resistance could happen 
by resistant organisms and/or genetic material carrying resistance genes. 
Because the WWTP is a link between human community and natural water 
environment, we aimed to investigate if and how the quantities of the resistance 
genes change during the sewage treatment process and if the WWTP contributes 
to the resistome in the natural environment. 
We sampled three different WWTPs, all from the Baltic Sea catchment area. 
Two WWTPs were located in Estonia (Tallinn and Tartu) and one in Finland 
(Helsinki). The WWTP in Tartu is the smallest and serves a population of 
~100,000 while the WWTP in Helsinki was the largest and serves a population 
of ~800,000. The WWTP in Tallinn serves a population of ~350,000. The 
process technology employed in all three is similar. Five groups of samples 
were taken from December 2011 to December 2012, with each group 
representing one season (winter was sampled twice). Each sampling group 
consisted of three sampling dates that were separated by one to three days. 
Multiple sampling dates were used to obtain a better representation of the 
seasonal average while minimizing weather and community fluctuations. 
We quantified seven resistance genes using quantitative PCR (qPCR), two 
resistance genes for sulphonamide (sul1 and sul2), two for tetracycline (tetM 
and tetC), and three giving resistance to β-lactams (blaoxa–58, blashv–34, and  
blactx–m–32). These antibiotics and their respective resistance genes represent 
clinically important resistance genes, have been found in MGEs, and all of the 
associated antibiotics are widely used. The selection of resistance genes was 
based on an initial experiment where we screened for the presence of additional 
tetracycline and β-lactamase genes at the Tartu WWTP and a similar screening 
from the Helsinki plant. Some of the resistance genes provide resistance against 
antibiotics that have been used for a long period of time (e.g. tetracycline and 
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sulphonamide) while some provide resistance against newer antibiotics. The  
β-lactamases studied provide resistance against extended spectrum β-lactams 
such as carbapenems, and 3rd and 4th generation cephalosporins (Poirel et al. 
2010b; Szczepanowski et al. 2009; Pfeifer et al. 2010). 
We quantified the number of bacteria in both the inflow and outflow of each 
WWTP using the 16S rDNA copy number in the extracted DNA. As expected, 
the 16S rDNA quantities were orders of magnitudes lower in the effluent than in 
the inflow (III, Figure 1A). The highest drop was in the Tallinn WWTP with 
1×1010 16S rDNA copies per ml (SD 3×1010) in the inflow and 1×108 (SD 
2×108) in the effluent. The differences in the quantity of 16S rDNA between the 
inflow and effluent were statistically significant in all studied WWTPs (adjusted 
p<0.01) (III, Figure 1A). 
The raw copy numbers of resistance genes per ml were decreased during the 
purification process in the WWTPs and the levels of detected resistance genes 
were lower in the effluent than in inflow (III, Figure 1B), although, the decrease 
is not statistically significant for all resistance gene in every WWTP. For the 
WWTP in Helsinki, the decrease in detected resistance genes was statistically 
significant (p<0.01) for every resistance gene. In Tallinn WWTP, the decrease 
was significant (p<0.01) for all resistance genes except blashv–34 (p > 0.05). In 
Tartu WWTP the raw copy numbers for the resistance genes studied decreased 
from the inflow to effluent but only three were statistically significant:  
blactx–m–32 and tetM (p < 0.01), and, to a lesser degree, blaoxa–58 (p = 0.03). The 
decrease in raw copy number is similar to previously published data (Gao et al. 
2012; Zhang et al. 2009; Auerbach et al. 2007). We found in our study that the 
resistance genes for “older” antibiotics (except tetC) were more commonly 
detected. sul1, sul2, and tetM were present above limit of quantification in all 
sites and samples (III, Table 3 and Supplemental Figure 2). 
To both avoid inconsistencies between qPCR assays and allow one to 
compare results between various extraction methods, we normalised the raw 
resistance gene copy numbers with 16S rDNA copy numbers. It is known that 
the raw qPCR numbers differ between extraction times and these methods are 
not directly comparable, however, copy number ratios tend to be more reliable 
(Kubo et al. 2012; Lloyd et al. 2013). The amplification efficiencies between 
quantification assay 1 and 2 for the various genes in our study is close (III, 
Table 1). Comparing relative abundances, only four cases were statistically 
significant (p<0.01) (III, Figure 2). blaoxa–58 and tetC from the Helsinki plant 
and tetM from the WWTP in Tallinn decreased after purification in the effluent 
samples. In addition, we observe an increase in blashv–34 resistance genes in the 
Tallinn WWTP, which is statistically significant. For all other resistance genes 
studied, in all samples, the purification process had no significant effect on the 
relative copy numbers of the resistance genes. From this we conclude that there 
is neither considerable enrichment nor removal of antibiotic resistance genes 
during the processes in all three WWTPs (Figure 2) at the community level. Our 
observation that the abundance of resistance genes changes in accordance with 
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bacterial abundance has been observed in previous quantitative studies that 
normalised their results with the quantity of 16S rDNA (Munir et al. 2011; Gao 
et al. 2012). 
Previous studies have reported that there is a relationship between the 
change in ARG abundance and nutrient removal efficiency and temperature 
(Nõlvak et al. 2013; Novo & Manaia 2010). In our study we also examined if 
water quality measures, such as total nitrogen, total phosphorus, biological 
oxygen demand, and suspended solids, are able to predict the efficiency of ARG 
removal. However, we did not find any relationship between the quality 
measures monitored and the abundances of ARGs (III, Supplemental Figure 4). 
This means that in our case, the changes in ARG abundance did not depend on 
either the treatment technology employed or operating conditions in the 
WWTPs, but rather in the general decrease in the total population of bacteria. 
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CONCLUSIONS 
 Bacterial genera from aquatic samples display a heterogeneous antibiotic 
resistance distribution. Each genus displayed a continuum of resistance 
coefficients ranging from 0 to 1 and multidrug resistance was randomly 
distributed in both the population and between genera. 
 Despite the random distribution of multi drug resistance genes, some forms 
of resistance display a statistically significant (p<0.05) correlation. 
Chloramphenicol and tetracycline display a highly significant positive 
correlation over the entire study population, with even higher correlation 
among specific genera (e.g. Aeromonas). 
 Medically relevant beta-lactam class ampC FOX family genes can be found 
in freshwater bacterial populations. However, the environmental FOX genes 
cluster separately from medical sequences using data obtained in public 
databases. 
 Aeromonas spp. and Pseudomonas spp. are the main carriers of FOX 
resistance genes. Based on the results of multilocus sequence typing, FOX 
gene carriers group separately from non-carriers in the genus Aeromonas. 
 Resistance genes for antibiotics that have been in use for longer were more 
commonly detected in the wastewater treatment plant than resistance genes 
against newer antibiotics. 
 The raw abundance of resistance genes decreased for all resistance genes 
during the wastewater treatment process, however, the decrease of relative 
abundance was significant only for blaoxa–58 and tetC in Helsinki plant, and 
decrease for tetM and increase for blashv–34 in Tallinn plant. 
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SUMMARY IN ESTONIAN 
Kas veekeskkond on antibiootikumiresistentsuse allikas, 
vahelüli või lõpp-punkt? 
Antibiootikumide kasutuselevõtuga eelmise sajandi alguses arvati, et bakteriaal-
setele haigustele on suudetud lõplik löök anda. Enne antibiootikumide 
kasutuselevõttu võis tänapäeval kergelt ravitav haigus olla raskesti ravitav või 
lausa surmav. Seetõttu nimetati antibiootikumid koheselt ka imeravimiteks ning 
ootused maailmaparandamisele olid suured nii spetsialistide hulgas kui ka 
üldise elanikkonna seas. 
Enamus tänapäeval kasutuses olevaid antibiootikume on esialgselt avastatud 
keskkonna mikroorganismidelt. Looduses arvatakse antibiootikumide roll olevat 
kaitse konkurentsi eest. Penitsilliini ja streptomütsiini avastamine tõi endaga 
kaasa massilise ravimikandidaatide sõelumise mikroorganismidest ja kõige 
rohkem tänaseid ravimeid on avastatud ühest bakteriperekonnast – Strepto-
mycesest. 
Juba kohe alguses kui antimikroobsed ained kasutusele võeti oli neid, kes 
hoiatasid resistentsuse eest, mis tähendab, et ravim ei suuda kõrvaldada 
haigustekitajat bakteripopulatsiooni – haigus ei allu ravile. Uusi ravimeid 
avastati üha juurde ja turulejõudmine oli samuti kiire, mis lubas resistentsuse 
vastu võidelda uue ravimi kasutuselevõtuga. Tänaseks on paljugi muutunud. 
Uusi antibiootikumide klasse ei ole avastatud peale 1980ndaid aastaid. Põhjused 
peituvad arenduse ja turuletoomise kalliduses ning resistentsuse kiires 
esiletõusus ja levikus üle maailma, mis ei lase teenida tagasi arenduskulusid ja 
pärsib ravimifirmade huvi. 
Nii nagu antibiootikumid on pärit loodusliku keskkonna mikroorganismidelt, 
on ka resistentsus antibiootikumidele evolutsioneerunud looduses koos 
antibiootikumide evolutsiooniga. Samas, tuleb mainida, et antimikroobsete 
ravimite kasutamine inimeste poolt on mõjutanud ka resistentset populatsiooni 
keskkonnas. Uuring, mis viidi läbi Hollandi pinnaseproovidega näitas, et 
resistentsete bakterite proportsioon on ajas järkjärgult suurenenud. Resistentsete 
bakterite levik ei ole piiratud inimlähedaste keskkondadega. Baktereid, kes 
suudavad üle elada ravikuuri on leitud kaugetest maailmanurkadest: näiteks 
Andide mäestikujärvest ja liustiku proovidest üle maailma. Üks osa antud tööst 
oli iseloomustada resistentset bakteripopulatsiooni Eestis, Suur-Emajões. 
Selleks võeti proove neljal järjestikusel kuul 2008 aastal. Proovivõtu kohti oli 
kaks: Tartust ülesvoolu ja allavoolu. Proovid külvasime me selektiivsöötmele 
(sisaldasid ühte antibiootikumi) ja kasvatasime ülesse bakterikolooniad ning 
valitud kolooniatel määrasime fülogeneetilise kuuluvuse. 
Leidsime, et suure hulga meie valitud kogumist moodustasid Gamma-
proteobacteria, mille hulgast olid kõige arvukam perekond Pseudomonas. 
Lisaks olid arvukamad perekonnad Stenotrophomonas, Chryseobacterium ja 
12
46 
Aeromonas. Kõikide nimetatud perekondade hulgas leidub ka olulisi 
patogeenseid liike. 
Üks suurimaid muresid antibiootikumiresistentsete patogeenide juures on 
see, et nad võivad olla resistentsed mitmetele antibiootikumidele. Kui 
resistentsus oleks ainult ühe antibiootikumi suhtes, oleks ravi siiski suhteliselt 
lihtne – võta järgmine ravim. Multiresistentsus, resistentsus mitme ravimi 
suhtes, seda teha ei võimalda. Lisaks kulutab kõiksugu testimine ja sobiva 
ravimi leidmine väärtuslikku aega. Multiresistentsus ei esine ainult seal, kus 
antibiootikume laialt kasutatakse, vaid on laialt levinud ka looduses. Seda on 
näidanud nii varasemad tööd kui ka meie enda töös. Nägime, et enamus 
perekondi olid resistentsed rohkem kui ühe antibiootikumi suhtes. Samas 
leidsime, et testitud 6 antibiootikumi suhtes ei olnud ükski vaadeldud pere-
kondadest täielikult resistentne. Vähemalt üks ravim oli võimeline enamust 
bakteritest perekonnas hävitama. Multiresistentsus oli normaaljaotusega, mis 
näitab, et ühte superresistentset populatsiooni uuritavate bakterite hulgas ei 
olnud. Uurisime ka resistentsuste koosesinemist organismide kaupa ja leidsime, 
et tetratsükliini ja klooramfenikooli koosesinemisel oli statistiliselt oluline 
(p<0,05) kõrge korrelatsioonikoefitsient. Seda nii üle kogu uuritava 
populatsiooni kui ka üksikute perekondade seas. Selline seotus võib viidata 
resistentsusgeenide paiknemisele ühel mobiilsuselemendil. Geneetilised mobiil-
sed elemendid on molekulid, millega on võimalik üle kanda geneetilist materjali 
ühest mitte-järglasrakust teise. Selline kandumine on ka üheks antibiootikumi 
resistentsuse kiireks levikuks ühest organismist teise ja ka erinevate 
geograafiliste keskkondade vahel. 
Resistentsusgeenide liikumine, kas geneetilise materjalina või organismi-
dega, ja selle suund on oluline küsimus takistamaks resistentsuse levikut ja 
teket. Geenid, mis tagavad resistentsuse on keskkonnas olemas. On olemas nii 
vanade ja keskkonnas pärit antibiootikumide suhtes kui ka uute täissünteetiliste 
vastu. Ühe osana üritab ka antud töö vaadata inimese mõju keskkonnale 
antibiootikumide resistentsuse seisukohalt. Seda, et resistentsed organismid on 
vesikeskkonnas olemas me näitasime. Näitasime ka resistentsusgeenide olemas-
olu, mis on sarnane patogeensetest tüvedest leitud geeniga. Selline otsene seos 
viitab selgelt keskkondade seotusele ja võimalikule ohule, mis loodus võib 
meditsiinis põhjustada. 
Kolmandana uurisime kas reovee puhastusjaamas toimuvad protsessid, mille 
järel lastakse puhastatud vesi taas loodusesse, võib mõjutada sealset kooslust. 
Teaduskirjanduses avaldatu põhjal võib teha järelduse, et reovee puhastus-
jaamad on kohad, kus resistentsus võib levida erinevate organismide vahel ning 
sealt edasi keskkonda. Puhastusjaama jõudvas reovees on antibiootikumide 
jääke ja patogeenseid liike ning puhastusjaamas on soodsad tingimused 
resistentsusgeenide vahetuseks erinevate organismide vahel. Meie uurisime 
kvantitatiivselt resistentsusgeenide hulga muutust puhastatud vees võrreldes 
reoveega. Võrdlesime seitset erinevat antibiootikumidele resistentsust põhjus-
tavat geeni: kaks tetratsükliini, kaks sulfonamiidi ja kolm geeni beta-laktaamide 
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vastu. Proovid olid võetud kolmest erinevast puhastusjaamast – Tartust, 
Tallinnast ja Helsingist, Soomest – ja proove võeti aasta jooksul, igal aastaajal. 
Kõik resistentsusgeenid olid kõikidest puhastusjaamadest leitavad, kuid mitte 
kõikides proovides. Kui me vaatasime uuritud geenide arvukuse toorandmeid, 
siis kõikide arvukus oli puhastatud vees langenud võrreldes reoveega, kuid 
muutus ei olnud kõikidel kordadel statistiliselt oluline. Toorandmete võrdlemine 
erinevate tööde, DNA eraldusmeetodite ja mõõtmistingimuste vahel ei ole 
parim praktika. Kitsaskoha vältimiseks mõõtsime samuti bakteri ribosomaalse 
geeni hulka proovides, mis näitab meile kaudselt proovis olevate bakterite 
hulka. Peale geeni hulkade normaliseerimist bakteriaalse arvukusega oli näha, et 
tegelikult mingit suhtelist resistentsusgeenihulga suurenemist ega vähenemist ei 
toimunud. Geenide hulk vähenes bakterite hulga vähenemisega puhastatavas 
vees. Tulemused näitavad, et uuritud geenide hulgad reoveepuhastusjaamas ei 
suurene, siis mingi osa jõuab siiski ka loodusesse. 
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